IL17A and metabolic dysfunction-associated steatotic liver disease: In NAFLD patients, increased frequency of intrahepatic IL-17+ cells, along with an increased Th17/Treg ratio in both peripheral blood and liver tissues, have been associated with the progression from hepatic steatosis to NASH [70].